Citation Impact
Citing Papers
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Acute hepatitis C and HIV coinfection
2009
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
2009
Genetic variation inCLDN1and susceptibility to hepatitis C virus infection
2009 StandoutNobel
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Hepatitis C Virus Genotypes and Viral Concentrations in Participants of a General Population Survey in the United States
2006
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection
2011
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The changing epidemiology of hepatitis C virus infection in Europe
2007
Acute hepatitis C: Current status and remaining challenges
2008
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Epidemiology and natural history of HCV infection
2013
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
The evaluation of renal function and disease in patients with cirrhosis
2010
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
The long and winding road leading to the identification of the hepatitis C virus
2009 StandoutNobel
Epidemiology of hepatitis C virus infection
2007
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
2002
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Acute Hepatitis C: A Systematic Review.
2008
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Energy Metabolism in the Liver
2014 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones
2015
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Adverse events associated with ERCP
2016 Standout
Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection
2008 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Insulin Degradation: Progress and Potential*
1998
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Comparison of Qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatment of HCV Infections
2005
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Effect of Weight Loss on Liver Free Fatty Acid Uptake and Hepatic Insulin Resistance
2008
Works of B Bastens being referenced
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.
2011
Hepatitis C Virus Genotype 5 in Southern Belgium: Epidemiological Characteristics and Response to Therapy
2005
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *
2003
Treatment of acute hepatitis C with interferon α‐2b: early initiation of treatment is the most effective predictive factor of sustained viral response
2004
Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium
2005
Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.
1993
HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin
2006
[Value of MRCP for detection of choledocholithiasis in symptomatic patients: one-year experience with a standardized high resolution breath-hold technique].
2001